What are the ethical considerations around CRISPR and genome editing in humans?

• A. Only safety concerns
• B. Safety and consent are the only issues
• C. Equity of access
• D. Safety, consent, potential for unintended off-target effects, equity of access, and germline modification implications

Answer: (D)

The key idea here is that ethical considerations around genome editing in humans require a broad, integrated view of both the science and its social impact. Safety is essential because editing could cause immediate harms or unpredictable long‑term effects, including edits that affect other genes (off‑target effects) or mosaic outcomes where not all cells are edited consistently. Consent matters because the people who undergo edits should understand the risks and benefits, but germline edits raise the even more complex issue that changes would be inherited by future generations who cannot consent to those modifications. Equity of access is crucial because powerful technologies tend to widen gaps if only some groups can benefit, so questions of fair distribution, pricing, and access must be addressed. Germline modification implications add layers of irreversibility and global governance concerns, since such changes affect the human gene pool and cross borders, raising debates about whether and how we should regulate heritable edits.

The comprehensive option is the best choice because it includes safety, consent, off‑target risks, equity of access, and the germline implications all together. Other choices leave out one or more important dimensions, risking an incomplete ethical assessment.